Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
the body’s immune system to fight cancer at all levels (https://cancer.osu.edu/piio ). Launched in July 2019 as part of a $102 Million pledge from Pelotonia (pelotonia.org), the PIIO represents Ohio State's
-
/InstituteRibeirao Preto Medical School - University if Sao PauloCountryBrazilState/ProvinceSao PauloCityRibeirao PretoGeofield Contact State/Province Sao Paulo City Ribeirao Preto Website https://www.fmrp.usp.br
-
involves basic immunological and cell biology assays, in vivo models, along with human specimens and trials. Our expertise is in radiation and immunotherapy combinations. Seeking passionate and driven
-
Support (BLS), or UC Davis Health CPR Within thirty (30) days of hire, obtain ONS/ONCC Chemotherapy Immunotherapy Certificate. Graduation from an accredited school of nursing Ability to read, write, speak
-
prevention of infections, e.g., vaccines and immunotherapies, with a significant global health impact. One of the main project is WORMVACS2.0, which objective is to establish an effective pipeline for helminth
-
of Denmark (DTU). At DTU Health Technology you will work with world leading scientists to explore new avenues and develop new technologies within the fast-developing field of immunology and immunotherapy. In
-
mapping the biological mechanisms behind why some patients respond to immunotherapy while others do not, we hope to improve future treatment strategies. We conduct advanced molecular analyses of tumor
-
Apply online now: https://karriere.klinikum.uni-heidelberg.de/index.php?ac=application&jobad_id=26557 PhD Student (f/m/d) Stellenanzeige merken Stellenanzeige teilen wanted for 01. February 2026
-
Dalhousie University | Halifax Mid Harbour Nova Scotia Provincial Government, Nova Scotia | Canada | about 1 hour ago
: https://dal.peopleadmin.ca/postings/20088 Canada Research Chairs Canada Impact+ Research Chairs candidates residing in Canada will also be considered for Canada Research Chairs, offering $200,000 per year
-
the discovery and clinical translation of next-generation immunotherapies, including first-in-human Phase I trials. The Center leverages UT Southwestern’s world-class infrastructure in cellular manufacturing